218 related articles for article (PubMed ID: 2698296)
21. The MPTP model of Parkinson's disease.
Smeyne RJ; Jackson-Lewis V
Brain Res Mol Brain Res; 2005 Mar; 134(1):57-66. PubMed ID: 15790530
[TBL] [Abstract][Full Text] [Related]
22. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
23. Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings.
Braungart E; Gerlach M; Riederer P; Baumeister R; Hoener MC
Neurodegener Dis; 2004; 1(4-5):175-83. PubMed ID: 16908987
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of MPTP toxicity.
Przedborski S; Jackson-Lewis V
Mov Disord; 1998; 13 Suppl 1():35-8. PubMed ID: 9613716
[TBL] [Abstract][Full Text] [Related]
25. MPTP toxicity: implications for research in Parkinson's disease.
Kopin IJ; Markey SP
Annu Rev Neurosci; 1988; 11():81-96. PubMed ID: 3129982
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide and reactive oxygen species in Parkinson's disease.
Tieu K; Ischiropoulos H; Przedborski S
IUBMB Life; 2003 Jun; 55(6):329-35. PubMed ID: 12938735
[TBL] [Abstract][Full Text] [Related]
27. Lack of major olfactory dysfunction in MPTP-induced parkinsonism.
Doty RL; Singh A; Tetrud J; Langston JW
Ann Neurol; 1992 Jul; 32(1):97-100. PubMed ID: 1642478
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective therapy for Parkinson's disease.
Koller WC
Exp Neurol; 1997 Mar; 144(1):24-8. PubMed ID: 9126147
[TBL] [Abstract][Full Text] [Related]
29. Abnormalities of the electron transport chain in idiopathic Parkinson's disease.
Parker WD; Boyson SJ; Parks JK
Ann Neurol; 1989 Dec; 26(6):719-23. PubMed ID: 2557792
[TBL] [Abstract][Full Text] [Related]
30. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
[TBL] [Abstract][Full Text] [Related]
31. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4-phenylpyridinium toxicity and complex I-IV damage in neuroblastoma cells.
Mazzio EA; Soliman KF
Biochem Pharmacol; 2004 Mar; 67(6):1167-84. PubMed ID: 15006552
[TBL] [Abstract][Full Text] [Related]
32. Studies on the toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) against mitochondria of mouse brain.
Mizuno Y; Sone N; Suzuki K; Saitoh T
J Neurol Sci; 1988 Aug; 86(1):97-110. PubMed ID: 3262717
[TBL] [Abstract][Full Text] [Related]
33. Probenecid potentiates MPTP/MPP+ toxicity by interference with cellular energy metabolism.
Alvarez-Fischer D; Noelker C; Grünewald A; Vulinović F; Guerreiro S; Fuchs J; Lu L; Lombès A; Hirsch EC; Oertel WH; Michel PP; Hartmann A
J Neurochem; 2013 Dec; 127(6):782-92. PubMed ID: 23802648
[TBL] [Abstract][Full Text] [Related]
34. MPTP and other Parkinson-inducing agents.
Schapira AH
Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):396-400. PubMed ID: 1623269
[TBL] [Abstract][Full Text] [Related]
35. Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress.
Abdulwahid Arif I; Ahmad Khan H
Toxicol Ind Health; 2010 Mar; 26(2):121-8. PubMed ID: 20207656
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis of Parkinson's disease.
Riederer P; Lange KW
Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):295-300. PubMed ID: 1623255
[TBL] [Abstract][Full Text] [Related]
37. [MPTP: a new chapter in the history of Parkinson's disease].
Piccinin GL; Piccirilli M; Finali G; Stefano E
Riv Neurol; 1989; 59(3):103-7. PubMed ID: 2688042
[TBL] [Abstract][Full Text] [Related]
38. Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.
McNaught KS; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
Biochem Pharmacol; 1998 Oct; 56(8):921-33. PubMed ID: 9776302
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of mitochondrial respiration by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain in vivo.
Mizuno Y; Suzuki K; Sone N; Saitoh T
Neurosci Lett; 1988 Sep; 91(3):349-53. PubMed ID: 3141846
[TBL] [Abstract][Full Text] [Related]
40. Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration.
McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
Biochem Pharmacol; 1996 Jun; 51(11):1503-11. PubMed ID: 8630091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
